Long-term Outcome for Open and Endoscopically Resected Sinonasal Tumors.


Journal

Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery
ISSN: 1097-6817
Titre abrégé: Otolaryngol Head Neck Surg
Pays: England
ID NLM: 8508176

Informations de publication

Date de publication:
05 2019
Historique:
pubmed: 5 12 2018
medline: 11 1 2020
entrez: 5 12 2018
Statut: ppublish

Résumé

Endoscopic resection of sinonasal cancer has become an alternative to open craniofacial surgery and leads to safe and satisfying results in emerging numbers. Randomized study data comparing outcomes between approaches are missing. Hence, it remains unclear which subgroups of patients might profit most from each technique. We aimed to identify such patient and tumor characteristics and gather information for future prospective study design. Case series with chart review. Tertiary academic center. This study is based on a retrospective chart review of 225 patients undergoing open craniofacial or endoscopic resection for sinonasal malignancy between 1993 and 2015 at Munich University Hospital. Statistical analyses include t test, chi-square, Kaplan-Meier charts, and univariate and multivariate analyses. The sample size was similar between the endoscopic and open surgery groups. Tumors were significantly larger in patients who underwent open craniofacial resection. The risk of notable bleeding ( P = .041) was lower and hospital stay shorter ( P = .001) for endoscopic interventions of all tumor stages. Rates of overall ( P = .024) and disease-specific ( P = .036) survival were significantly improved for endoscopic cases; improved recurrence-free survival rates did not achieve statistical significance ( P = .357). For cases matched for tumor size, this improvement was confirmed for T3 tumors ( P = .038). Regional and distant metastatic tumor spread generally worsened survival in both surgical subgroups. Multivariate Cox regression analysis revealed independent prognosticators for overall survival. Endoscopic tumor resection remains a suitable option for distinct indications and showed improved outcome in intermediate-stage tumors in our collective. Further randomized studies acknowledging the here-identified factors are needed to improve future therapy guidelines and patient care.

Identifiants

pubmed: 30511889
doi: 10.1177/0194599818815881
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

862-869

Auteurs

Jan Hagemann (J)

1 Department of Otolaryngology-Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.
2 Department of Otolaryngology-Head and Neck Surgery, Klinikum der Universität München, Munich, Germany.

Jana Roesner (J)

2 Department of Otolaryngology-Head and Neck Surgery, Klinikum der Universität München, Munich, Germany.

Soenke Helling (S)

2 Department of Otolaryngology-Head and Neck Surgery, Klinikum der Universität München, Munich, Germany.

Christian Jacobi (C)

3 Department of Otolaryngology-Head and Neck Surgery, Klinikum rechts der Isar, Technische Universität München, Munich, Germany.

Johannes Doescher (J)

4 Department of Otolaryngology-Head and Neck Surgery, Universitätsklinikum Ulm, Ulm, Germany.

Matthias Engelbarts (M)

1 Department of Otolaryngology-Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.

Julian Kuenzel (J)

1 Department of Otolaryngology-Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.

Philipp Krauss (P)

5 Department of Neurosurgery, UniversitätsSpital Zurich, Zurich, Switzerland.

Sven Becker (S)

1 Department of Otolaryngology-Head and Neck Surgery, Universitätsmedizin Mainz, Mainz, Germany.

Christian Stephan Betz (CS)

6 Department of Otorhinolaryngology, Universitätsklinikum Hamburg-Eppendorf, Hamburg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH